Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020
The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individu...
Gespeichert in:
| Veröffentlicht in: | PloS one 2022-07, Vol.17 (7), p.e0271788 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | e0271788 |
| container_title | PloS one |
| container_volume | 17 |
| creator | Acevedo, Andrea Feng, Wenhui Corlin, Laura Allen, Jennifer D Levine, Peter Stopka, Thomas J |
| description | The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individuals with regard to COVID-19 testing, susceptibility, and employment-related vulnerability.
We used data from a U.S. nationally representative survey (n = 1,208). Using logistic regressions, we examined whether individuals with SUDs differ from other individuals regarding underlying health conditions, COVID-19 testing, access to paid sick leave, and loss of employment. Data were collected in late May-early June, 2020.
Four percent of participants reported that a healthcare professional had told them they had a SUD. We found that, compared to those without SUDs, respondents with SUDs had higher odds of having lost their job due to the pandemic (adjusted odds ratio [AOR]:5.17, 95% confidence interval [CI]:2.28-11.74). Among individuals who were employed prior to the pandemic, people with SUDs had lower odds of having paid sick leave (AOR:0.26, 95% CI:0.09-0.74).
Our study indicates that individuals with SUDs could be disproportionately affected by COVID-19 economically, which might worsen SUD and racial/ethnic health disparities. |
| doi_str_mv | 10.1371/journal.pone.0271788 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2692658225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A711037116</galeid><doaj_id>oai_doaj_org_article_77745cad814941a498c7a3ec298c2870</doaj_id><sourcerecordid>A711037116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c641t-19998aaf8b3ed818ae75ec7e23c5a469b1dfb64ac2d0eb710982b95536f40ae63</originalsourceid><addsrcrecordid>eNqNk99u0zAUxiMEYmPwBggsISGQaPGfJE64QJrGgEqTJjG2W-vEOWk9pXGwnbE-Dy-K22bVinaBchHL5_d9Pj4-J0leMjplQrKP13ZwHbTT3nY4pVwyWRSPkkNWCj7JORWP760PkmfeX1OaiSLPnyYHIityLrL0MPlzetujM9hp9OS3CQsCXU3MsgcdPLENCQskJ-dXsy8TVpI-BnFpNKlWxA-VDxB1ZPBIauOtq9ER020kCK5dkX4BMRZddsIxfNmZgDW5CBDQfyLHRDvr_cSjDsbGW0V3d4OrD4RTTp8nTxpoPb4Y_0fJ5dfTnyffJ2fn32Ynx2cTnacsxPzKsgBoikpgXbACUGaoJXKhM0jzsmJ1U-UpaF5TrCSjZcGrMstE3qQUMBdHyeutb99ar8b6esXzkudZwXkWidmWqC1cq96ZJbiVsmDUZsO6uQIXjG5RSSnTTENMJC1TBmlZaAkCNY8LXkgavT6Ppw3VEmuNXXDQ7pnuRzqzUHN7o0oRXztNo8G70cDZXwP6oJbGa2xb6NAO27xlJvNCRPTNP-jDtxupOcQLmK6x8Vy9NlXHkjEau46tqzR9gIrf5oFjMzYm7u8J3u8JIhPwNsxh8F7NLn78P3t-tc--vccuENqw8LYd1h3k98F0C26azGGzKzKjaj1Ld9VQ61lS4yxF2av7D7QT3Q2P-Au_JxjX</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2692658225</pqid></control><display><type>article</type><title>Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Acevedo, Andrea ; Feng, Wenhui ; Corlin, Laura ; Allen, Jennifer D ; Levine, Peter ; Stopka, Thomas J</creator><contributor>Tadesse, Sebsibe</contributor><creatorcontrib>Acevedo, Andrea ; Feng, Wenhui ; Corlin, Laura ; Allen, Jennifer D ; Levine, Peter ; Stopka, Thomas J ; Tadesse, Sebsibe</creatorcontrib><description>The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individuals with regard to COVID-19 testing, susceptibility, and employment-related vulnerability.
We used data from a U.S. nationally representative survey (n = 1,208). Using logistic regressions, we examined whether individuals with SUDs differ from other individuals regarding underlying health conditions, COVID-19 testing, access to paid sick leave, and loss of employment. Data were collected in late May-early June, 2020.
Four percent of participants reported that a healthcare professional had told them they had a SUD. We found that, compared to those without SUDs, respondents with SUDs had higher odds of having lost their job due to the pandemic (adjusted odds ratio [AOR]:5.17, 95% confidence interval [CI]:2.28-11.74). Among individuals who were employed prior to the pandemic, people with SUDs had lower odds of having paid sick leave (AOR:0.26, 95% CI:0.09-0.74).
Our study indicates that individuals with SUDs could be disproportionately affected by COVID-19 economically, which might worsen SUD and racial/ethnic health disparities.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0271788</identifier><identifier>PMID: 35862354</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Alcohol use ; Benchmarks ; Biology and Life Sciences ; Complications and side effects ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 diagnostic tests ; COVID-19 Testing ; Cross-Sectional Studies ; Drug use ; Economic indicators ; Employee benefits ; Employment ; Ethnicity ; Family income ; Gender ; Geodemographics ; Health care ; Health risks ; Humans ; Internet access ; Language proficiency ; Medicine and Health Sciences ; Narcotics ; Pandemics ; Patient outcomes ; Polls & surveys ; Population ; Research and Analysis Methods ; Sick leave ; Social Sciences ; Substance abuse ; Substance use ; Substance use disorder ; Substance-Related Disorders - epidemiology ; Surveys ; United States - epidemiology ; Variables ; Viral diseases ; Women</subject><ispartof>PloS one, 2022-07, Vol.17 (7), p.e0271788</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Acevedo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Acevedo et al 2022 Acevedo et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c641t-19998aaf8b3ed818ae75ec7e23c5a469b1dfb64ac2d0eb710982b95536f40ae63</cites><orcidid>0000-0002-8564-6147 ; 0000-0002-3348-9063 ; 0000-0003-2314-8924</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302744/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302744/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2100,2926,23864,27922,27923,53789,53791,79370,79371</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35862354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Tadesse, Sebsibe</contributor><creatorcontrib>Acevedo, Andrea</creatorcontrib><creatorcontrib>Feng, Wenhui</creatorcontrib><creatorcontrib>Corlin, Laura</creatorcontrib><creatorcontrib>Allen, Jennifer D</creatorcontrib><creatorcontrib>Levine, Peter</creatorcontrib><creatorcontrib>Stopka, Thomas J</creatorcontrib><title>Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individuals with regard to COVID-19 testing, susceptibility, and employment-related vulnerability.
We used data from a U.S. nationally representative survey (n = 1,208). Using logistic regressions, we examined whether individuals with SUDs differ from other individuals regarding underlying health conditions, COVID-19 testing, access to paid sick leave, and loss of employment. Data were collected in late May-early June, 2020.
Four percent of participants reported that a healthcare professional had told them they had a SUD. We found that, compared to those without SUDs, respondents with SUDs had higher odds of having lost their job due to the pandemic (adjusted odds ratio [AOR]:5.17, 95% confidence interval [CI]:2.28-11.74). Among individuals who were employed prior to the pandemic, people with SUDs had lower odds of having paid sick leave (AOR:0.26, 95% CI:0.09-0.74).
Our study indicates that individuals with SUDs could be disproportionately affected by COVID-19 economically, which might worsen SUD and racial/ethnic health disparities.</description><subject>Alcohol use</subject><subject>Benchmarks</subject><subject>Biology and Life Sciences</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 diagnostic tests</subject><subject>COVID-19 Testing</subject><subject>Cross-Sectional Studies</subject><subject>Drug use</subject><subject>Economic indicators</subject><subject>Employee benefits</subject><subject>Employment</subject><subject>Ethnicity</subject><subject>Family income</subject><subject>Gender</subject><subject>Geodemographics</subject><subject>Health care</subject><subject>Health risks</subject><subject>Humans</subject><subject>Internet access</subject><subject>Language proficiency</subject><subject>Medicine and Health Sciences</subject><subject>Narcotics</subject><subject>Pandemics</subject><subject>Patient outcomes</subject><subject>Polls & surveys</subject><subject>Population</subject><subject>Research and Analysis Methods</subject><subject>Sick leave</subject><subject>Social Sciences</subject><subject>Substance abuse</subject><subject>Substance use</subject><subject>Substance use disorder</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>Surveys</subject><subject>United States - epidemiology</subject><subject>Variables</subject><subject>Viral diseases</subject><subject>Women</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk99u0zAUxiMEYmPwBggsISGQaPGfJE64QJrGgEqTJjG2W-vEOWk9pXGwnbE-Dy-K22bVinaBchHL5_d9Pj4-J0leMjplQrKP13ZwHbTT3nY4pVwyWRSPkkNWCj7JORWP760PkmfeX1OaiSLPnyYHIityLrL0MPlzetujM9hp9OS3CQsCXU3MsgcdPLENCQskJ-dXsy8TVpI-BnFpNKlWxA-VDxB1ZPBIauOtq9ER020kCK5dkX4BMRZddsIxfNmZgDW5CBDQfyLHRDvr_cSjDsbGW0V3d4OrD4RTTp8nTxpoPb4Y_0fJ5dfTnyffJ2fn32Ynx2cTnacsxPzKsgBoikpgXbACUGaoJXKhM0jzsmJ1U-UpaF5TrCSjZcGrMstE3qQUMBdHyeutb99ar8b6esXzkudZwXkWidmWqC1cq96ZJbiVsmDUZsO6uQIXjG5RSSnTTENMJC1TBmlZaAkCNY8LXkgavT6Ppw3VEmuNXXDQ7pnuRzqzUHN7o0oRXztNo8G70cDZXwP6oJbGa2xb6NAO27xlJvNCRPTNP-jDtxupOcQLmK6x8Vy9NlXHkjEau46tqzR9gIrf5oFjMzYm7u8J3u8JIhPwNsxh8F7NLn78P3t-tc--vccuENqw8LYd1h3k98F0C26azGGzKzKjaj1Ld9VQ61lS4yxF2av7D7QT3Q2P-Au_JxjX</recordid><startdate>20220721</startdate><enddate>20220721</enddate><creator>Acevedo, Andrea</creator><creator>Feng, Wenhui</creator><creator>Corlin, Laura</creator><creator>Allen, Jennifer D</creator><creator>Levine, Peter</creator><creator>Stopka, Thomas J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7T9</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8564-6147</orcidid><orcidid>https://orcid.org/0000-0002-3348-9063</orcidid><orcidid>https://orcid.org/0000-0003-2314-8924</orcidid></search><sort><creationdate>20220721</creationdate><title>Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020</title><author>Acevedo, Andrea ; Feng, Wenhui ; Corlin, Laura ; Allen, Jennifer D ; Levine, Peter ; Stopka, Thomas J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c641t-19998aaf8b3ed818ae75ec7e23c5a469b1dfb64ac2d0eb710982b95536f40ae63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alcohol use</topic><topic>Benchmarks</topic><topic>Biology and Life Sciences</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 diagnostic tests</topic><topic>COVID-19 Testing</topic><topic>Cross-Sectional Studies</topic><topic>Drug use</topic><topic>Economic indicators</topic><topic>Employee benefits</topic><topic>Employment</topic><topic>Ethnicity</topic><topic>Family income</topic><topic>Gender</topic><topic>Geodemographics</topic><topic>Health care</topic><topic>Health risks</topic><topic>Humans</topic><topic>Internet access</topic><topic>Language proficiency</topic><topic>Medicine and Health Sciences</topic><topic>Narcotics</topic><topic>Pandemics</topic><topic>Patient outcomes</topic><topic>Polls & surveys</topic><topic>Population</topic><topic>Research and Analysis Methods</topic><topic>Sick leave</topic><topic>Social Sciences</topic><topic>Substance abuse</topic><topic>Substance use</topic><topic>Substance use disorder</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>Surveys</topic><topic>United States - epidemiology</topic><topic>Variables</topic><topic>Viral diseases</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Acevedo, Andrea</creatorcontrib><creatorcontrib>Feng, Wenhui</creatorcontrib><creatorcontrib>Corlin, Laura</creatorcontrib><creatorcontrib>Allen, Jennifer D</creatorcontrib><creatorcontrib>Levine, Peter</creatorcontrib><creatorcontrib>Stopka, Thomas J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Linguistics and Language Behavior Abstracts (LLBA)</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Acevedo, Andrea</au><au>Feng, Wenhui</au><au>Corlin, Laura</au><au>Allen, Jennifer D</au><au>Levine, Peter</au><au>Stopka, Thomas J</au><au>Tadesse, Sebsibe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2022-07-21</date><risdate>2022</risdate><volume>17</volume><issue>7</issue><spage>e0271788</spage><pages>e0271788-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The coronavirus disease 2019 (COVID-19) pandemic could disproportionately affect individuals who have a substance use disorder (SUD). However, little information exists on COVID-19-related experiences among individuals with a SUD. We examined whether individuals with a SUD differ from other individuals with regard to COVID-19 testing, susceptibility, and employment-related vulnerability.
We used data from a U.S. nationally representative survey (n = 1,208). Using logistic regressions, we examined whether individuals with SUDs differ from other individuals regarding underlying health conditions, COVID-19 testing, access to paid sick leave, and loss of employment. Data were collected in late May-early June, 2020.
Four percent of participants reported that a healthcare professional had told them they had a SUD. We found that, compared to those without SUDs, respondents with SUDs had higher odds of having lost their job due to the pandemic (adjusted odds ratio [AOR]:5.17, 95% confidence interval [CI]:2.28-11.74). Among individuals who were employed prior to the pandemic, people with SUDs had lower odds of having paid sick leave (AOR:0.26, 95% CI:0.09-0.74).
Our study indicates that individuals with SUDs could be disproportionately affected by COVID-19 economically, which might worsen SUD and racial/ethnic health disparities.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>35862354</pmid><doi>10.1371/journal.pone.0271788</doi><tpages>e0271788</tpages><orcidid>https://orcid.org/0000-0002-8564-6147</orcidid><orcidid>https://orcid.org/0000-0002-3348-9063</orcidid><orcidid>https://orcid.org/0000-0003-2314-8924</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2022-07, Vol.17 (7), p.e0271788 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2692658225 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Alcohol use Benchmarks Biology and Life Sciences Complications and side effects Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 diagnostic tests COVID-19 Testing Cross-Sectional Studies Drug use Economic indicators Employee benefits Employment Ethnicity Family income Gender Geodemographics Health care Health risks Humans Internet access Language proficiency Medicine and Health Sciences Narcotics Pandemics Patient outcomes Polls & surveys Population Research and Analysis Methods Sick leave Social Sciences Substance abuse Substance use Substance use disorder Substance-Related Disorders - epidemiology Surveys United States - epidemiology Variables Viral diseases Women |
| title | Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A39%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experiences%20with%20and%20impacts%20of%20the%20COVID-19%20pandemic%20by%20substance%20use%20disorder%20in%20the%20early%20phase%20of%20pandemic%20in%20the%20United%20States:%20A%20cross-sectional%20survey,%202020&rft.jtitle=PloS%20one&rft.au=Acevedo,%20Andrea&rft.date=2022-07-21&rft.volume=17&rft.issue=7&rft.spage=e0271788&rft.pages=e0271788-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0271788&rft_dat=%3Cgale_plos_%3EA711037116%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2692658225&rft_id=info:pmid/35862354&rft_galeid=A711037116&rft_doaj_id=oai_doaj_org_article_77745cad814941a498c7a3ec298c2870&rfr_iscdi=true |